Add Company
Join Now

NephCure Revenue and Competitors

License our Company Data API

PA USA

Location

N/A

Total Funding

Nonprofit

Industry

Estimated Revenue & Valuation

  • NephCure's estimated annual revenue is currently $8.7M per year.(i)
  • NephCure's estimated revenue per employee is $140,000

Employee Data

  • NephCure has 62 Employees.(i)
  • NephCure grew their employee count by 32% last year.

NephCure's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VPReveal Email/Phone
3
Executive Director DevelopmentReveal Email/Phone
4
Associate Director, DevelopmentReveal Email/Phone
5
Director, Strategic OperationsReveal Email/Phone
6
National DirectorReveal Email/Phone
7
Government Relations and Advocacy DirectorReveal Email/Phone
8
Executive Director Patient EngagementReveal Email/Phone
9
Director, Marketing and CommunicationsReveal Email/Phone
10
Associate Director Community EngagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.6M836%N/AN/A
#2
$7.5M15119%N/AN/A
#3
$5.2M3754%N/AN/A
#4
$3.5M10%N/AN/A
#5
$7.5M590%N/AN/A
#6
$7.5M37-14%N/AN/A
#7
$35M7314%N/AN/A
#8
$7.5M965%N/AN/A
#9
$1.7M53-2%N/AN/A
#10
$75M17345%N/AN/A
Add Company

What Is NephCure?

NephCure's mission is to empower people with rare, protein-spilling kidney disease to take charge of their health, while leading the revolution in research, new treatments, and care.\n\nNephCure is squarely focused on nephrotic syndrome, FSGS, IgAN, and other rare, protein-spilling kidney diseases. NephCure acts as the connector amongst patients and families, healthcare providers, government agencies, industry partners, and other key stakeholders, while also guiding patients to the best care and treatment options possible.\n\nNephCure is a U.S. tax exempt 501 (c)(3) public charity established in 2000.

keywords:N/A

N/A

Total Funding

62

Number of Employees

$8.7M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.3M62-26%N/A
#2
$8.1M6238%N/A
#3
$8.1M62-2%N/A
#4
$3.5M62-2%N/A
#5
$15.6M629%N/A